IL109532A - Compositions comprising coumarin derivatives in the form of solid dispersions - Google Patents

Compositions comprising coumarin derivatives in the form of solid dispersions

Info

Publication number
IL109532A
IL109532A IL109532A IL10953294A IL109532A IL 109532 A IL109532 A IL 109532A IL 109532 A IL109532 A IL 109532A IL 10953294 A IL10953294 A IL 10953294A IL 109532 A IL109532 A IL 109532A
Authority
IL
Israel
Prior art keywords
pct
compositions
solid dispersions
coumarin derivatives
date nov
Prior art date
Application number
IL109532A
Other languages
English (en)
Other versions
IL109532A0 (en
Original Assignee
Basf Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Basf Ag filed Critical Basf Ag
Publication of IL109532A0 publication Critical patent/IL109532A0/xx
Publication of IL109532A publication Critical patent/IL109532A/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365Lactones
    • A61K31/366Lactones having six-membered rings, e.g. delta-lactones
    • A61K31/37Coumarins, e.g. psoralen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425Thiazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/433Thidiazoles

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Jellies, Jams, And Syrups (AREA)
  • Cephalosporin Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Detergent Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
IL109532A 1993-05-18 1994-05-03 Compositions comprising coumarin derivatives in the form of solid dispersions IL109532A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4316537A DE4316537A1 (de) 1993-05-18 1993-05-18 Zubereitungen in Form fester Lösungen

Publications (2)

Publication Number Publication Date
IL109532A0 IL109532A0 (en) 1994-08-26
IL109532A true IL109532A (en) 1997-11-20

Family

ID=6488330

Family Applications (1)

Application Number Title Priority Date Filing Date
IL109532A IL109532A (en) 1993-05-18 1994-05-03 Compositions comprising coumarin derivatives in the form of solid dispersions

Country Status (23)

Country Link
US (1) US5684040A (da)
EP (1) EP0697867B1 (da)
JP (1) JPH08510219A (da)
KR (1) KR960702305A (da)
CN (1) CN1123524A (da)
AT (1) ATE209913T1 (da)
AU (1) AU688328B2 (da)
BR (1) BR9406414A (da)
CA (1) CA2163255A1 (da)
CZ (1) CZ300895A3 (da)
DE (2) DE4316537A1 (da)
DK (1) DK0697867T3 (da)
ES (1) ES2169073T3 (da)
FI (1) FI955524A0 (da)
HR (1) HRP940305A2 (da)
HU (1) HUT73657A (da)
IL (1) IL109532A (da)
NO (1) NO954660D0 (da)
NZ (1) NZ267080A (da)
PL (1) PL311698A1 (da)
SI (1) SI9420035A (da)
WO (1) WO1994026267A1 (da)
ZA (1) ZA943368B (da)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10026698A1 (de) * 2000-05-30 2001-12-06 Basf Ag Selbstemulgierende Wirkstoffformulierung und Verwendung dieser Formulierung
DE60143704D1 (de) * 2000-09-25 2011-02-03 Nippon Shinyaku Co Ltd Verfahren zur herstellung einer medizinischen festen dispersion
MXPA03011784A (es) 2001-06-22 2004-04-02 Pfizer Prod Inc Composiciones farmaceuticas de dispersiones de farmacos y polimeros neutros.
WO2003000292A1 (en) * 2001-06-22 2003-01-03 Pfizer Products Inc. Pharmaceutical compositions comprising low-solubility and/or acid-sensitive drugs and neutralized acidic polymers
MXPA03011935A (es) * 2001-06-22 2004-03-26 Pfizer Prod Inc Composiciones farmaceuticas que contienen conjuntos de polimero y farmaco.
US20040015519A1 (en) * 2001-10-15 2004-01-22 Yukitoshi Maeda Content delivery server and content delivery system having the same
PL371416A1 (en) 2002-02-01 2005-06-13 Pfizer Products Inc. Controlled release pharmaceutical dosage forms of a cholesteryl ester transfer protein inhibitor
AR038375A1 (es) 2002-02-01 2005-01-12 Pfizer Prod Inc Composiciones farmaceuticas de inhibidores de la proteina de transferencia de esteres de colesterilo
AU2003249474A1 (en) 2002-08-12 2004-02-25 Pfizer Products Inc. Pharmaceutical compositions of semi-ordered drugs and polymers
US7704528B2 (en) * 2003-05-05 2010-04-27 Isp Investments Inc. Binder composition and method for processing poorly compressible drugs into tablets of predetermined hardness and friability
WO2005005401A1 (ja) * 2003-07-11 2005-01-20 Osaka Industrial Promotion Organization スルホン酸エステル化合物およびそれを用いた蛍光プローブ
EP1650200A4 (en) * 2003-07-11 2008-03-19 Osaka Ind Promotion Org SULPHONATE COMPOUND AND FLUORESCENCE ENCODER USING THIS
EP1832281A1 (en) * 2006-03-10 2007-09-12 Abbott GmbH & Co. KG Process for producing a solid dispersion of an active ingredient

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS542316A (en) * 1977-06-07 1979-01-09 Yamanouchi Pharmaceut Co Ltd Solid pharmaceutical composition containing nifedipene
JPS5446837A (en) * 1977-09-19 1979-04-13 Kanebo Ltd Easily absorbable nifedipin composition, its preparation, and anti-stenocardia containing the same
BE880713A (fr) * 1978-12-21 1980-06-19 Sandoz Sa Nouvelles compositions pharmaceutiques solides a base d'alcaloides de l'ergot de seigle, permettant une liberation controlee de ce principe actif
DE3243158A1 (de) * 1982-11-23 1984-05-24 Basf Ag, 6700 Ludwigshafen Neue sulfonsaeureester von hydroxycumarinen, ihre herstellung und sie enthaltende arzneimittel
JPS6038322A (ja) * 1983-08-11 1985-02-27 Fujisawa Pharmaceut Co Ltd ジヒドロピリジンa物質含有易溶性固形製剤
GB8608080D0 (en) * 1986-04-02 1986-05-08 Fujisawa Pharmaceutical Co Solid dispersion composition
DE3612212A1 (de) * 1986-04-11 1987-10-15 Basf Ag Verfahren zur herstellung von festen pharmazeutischen formen
JP2636265B2 (ja) * 1987-10-06 1997-07-30 萬有製薬株式会社 脳循環改善剤
DE3830355A1 (de) * 1988-09-07 1990-03-15 Basf Ag Verfahren zur herstellung von pharmazeutischen tabletten
DE3834860A1 (de) * 1988-10-13 1990-04-19 Basf Ag Heterocyclisch substituierte alkoxycumarine, verfahren zu ihrer herstellung und diese enthaltende therapeutische mittel

Also Published As

Publication number Publication date
DE4316537A1 (de) 1994-11-24
AU688328B2 (en) 1998-03-12
CA2163255A1 (en) 1994-11-24
NZ267080A (en) 1996-11-26
EP0697867A1 (de) 1996-02-28
FI955524A7 (fi) 1995-11-16
DE59409994D1 (de) 2002-01-17
JPH08510219A (ja) 1996-10-29
FI955524L (fi) 1995-11-16
FI955524A0 (fi) 1995-11-16
EP0697867B1 (de) 2001-12-05
PL311698A1 (en) 1996-03-04
NO954660L (no) 1995-11-17
HU9503296D0 (en) 1996-01-29
ZA943368B (en) 1995-11-17
WO1994026267A1 (de) 1994-11-24
AU6926394A (en) 1994-12-12
CN1123524A (zh) 1996-05-29
SI9420035A (en) 1996-06-30
HRP940305A2 (en) 1996-12-31
KR960702305A (ko) 1996-04-27
DK0697867T3 (da) 2002-03-11
HUT73657A (en) 1996-09-30
CZ300895A3 (en) 1996-02-14
US5684040A (en) 1997-11-04
IL109532A0 (en) 1994-08-26
ES2169073T3 (es) 2002-07-01
BR9406414A (pt) 1995-12-19
NO954660D0 (no) 1995-11-17
ATE209913T1 (de) 2001-12-15

Similar Documents

Publication Publication Date Title
CA2326756A1 (en) Pharmaceutical compositions containing compounds with activity for the enhancement of absorption of active ingredients
ZA943368B (en) Compositions in the form of solid dispersions
IL137882A0 (en) Nanoparticles comprising at least one polymer and at least one compound able to complex one or more active ingredients
CA2265767A1 (en) Stable pharmaceutical composition including 4,5-epoxy-morphinan derivative
TR199801179T2 (xx) Yeni taksoitler, bunlar�n haz�rlanmalar� ve ila� bile�imleri.
GEP20002211B (en) Taxoids, Preparation Thereof, Pharmaceutical Compositions Containing Same
DE69401204D1 (de) Gonadotropin enthaltende gefriergetrocknete troepfen
CA2182582A1 (en) Compositions containing micronized nebivolol
IL76023A0 (en) Stable salts of s-adenosyl-l-methionine(sam)with polyanions
CA2247848A1 (en) Nitric oxide donors capable of reducing toxicity from drugs
CA2022177A1 (en) Arginine deiminase, its manufacturing method, and an anti-cancer agent containing this enzyme as an effective ingredient
ZA909124B (en) Derivatives of aromatic benzoates as inhibitors of esterase-producing micro-organisms
TR199901274T2 (xx) Farnezil protein transferaz inhibit�rleri olarak yararl� yeni trisiklik piperidinil bile�ikleri
ZA991546B (en) Streptogramin derivatives, their preparation and compositions containing them.
TW324651B (en) Microemulsion compositions of 3-isothiazolone compounds
NO973401L (no) Kortikosteroidinneholdende sammensetninger og fremstilling derav
DE69837999D1 (en) Herbizide furanyl- und thienyloxyazine
AU6878900A (en) 1,4-dihydropyridine-5-carboxylic acid ester derivatives and method for the preparation thereof
CA2079466A1 (en) Novel benzopyran derivatives and an anti-allergic agent possessing the same as the active ingrediant
ES2006521A6 (es) Composicion de control de plagas procedimiento derivados benzopiranicos y benzotiopiranicos y metodo de preparar dicha composicion
AU7610194A (en) Thiocarbamoyl compounds used as antimicrobial agents
GR970100096A (el) Εξωτερικη διαταξη κατα των παρασιτων για βοοειδη με βαση τη ν-φαινυλπυραζολη, ειδικα σκουλαρικια.
MY111499A (en) 1 - < [ - cyclopropyl - - (substituted oxy) - o - tolyl] sulfamoyl> -3- (4,6- dimethoxy - 2 - pyrimidinyl) urea herbicidal agents
IT1273455B (it) Derivati tiolici ad attivita' inibitrice delle metallopeptidasi
BR9106740A (pt) Formulacao diluidora proporcionando propriedades de sustentacao a produtos agricolas

Legal Events

Date Code Title Description
FF Patent granted
RH Patent void